ASTRAZENECA Vaccine for COVID-19 (A Hope) - a brief report on the journey of Astrazeneca and their mechanism
ASTRAZENECA - A HOPE FOR COVID 19 VACCINE - Souti Das ASTRAZENECA Do you know that it is not the name of the vaccine ; it is the company sponsored behind the vaccine design. Okay let‟s get into this. The company was founded in 1999 (6th April 1999) through the merger of the Swedish Astra AB (formed in mid 1890s) and the British Zeneca (formed in 1993) Group. Current CEO- Pascal Soriot (1st Oct 2012- present) Chairperson- Leif Johansson Today, AstraZeneca is working actively over 100 different countries and employs over 57,200 people – 46% in Europe, 31% in the Americas and 23% in Asia-Pacific. Its mission is “ to make a meaningful difference to patient health through great medicines that bring benefit for patients and add value for our stakeholders and society ” In 2010 AstraZeneca realized the market need that they should make bold changes to increase „success factor‟ by in-depth R&D result. As a result, they launched the „5R framework‟, which based upon quality over qua